Logo for Mersana Therapeutics Inc

Mersana Therapeutics Investor Relations Material

Latest events

Logo for Mersana Therapeutics Inc

Q4 2023

Mersana Therapeutics
Logo for Mersana Therapeutics

Q4 2023

28 Feb, 2024
Logo for Mersana Therapeutics

Corporate Presentation

5 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Mersana Therapeutics Inc., is a biopharmaceutical company focused on discovering and developing a pipeline of antibodies with differentiated and complementary means of targeting cancer. The Company’s lead product candidate is XMT-1522, an ADC that targets the CD38 antigen present on multiple hematological cancers. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics Inc. in November 2005. Mersana Therapeutics Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.